Ann Kimball & John W. Johnson Center for Cellular Therapeutics

The Ann Kimball & John W. Johnson Center for Cellular Therapeutics (KJCCT), or the “Johnson’s Center,” is a 5000 sq. ft. facility that includes 1710 sq. ft. of cleanroom space, a dedicated quality control laboratory, support spaces, and material, equipment, and cryogenic storage required for GMP operations.

Six independent production rooms, furnished with state-of-the-art equipment, will allow investigators—with support from our expert personnel—to translate laboratory discoveries into cutting-edge cellular therapies for patient care.

Combined with a fully equipped, in-house quality control laboratory for comprehensive testing and release of products, KJCCT offers HM the ability to deliver new cellular therapies to our patients in the safest, most cost-efficient, and rapid manner.

Core Director:

Daniel Kota, PhD
Director, Office of Translational Production & Quality; Director, cGMP Core
713.208.0639